Pacific Sun Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$286K Hold
1,136
0.12% 175
2026
Q1
$247K Hold
1,136
0.12% 180
2025
Q4
$260K Hold
1,136
0.13% 170
2025
Q3
$263K Hold
1,136
0.13% 169
2025
Q2
$211K Hold
1,136
0.11% 178
2025
Q1
$238K Hold
1,136
0.14% 163
2024
Q4
$202K Hold
1,136
0.11% 180
2024
Q3
$224K Buy
+1,136
New +$212K 0.12% 172
2024
Q2
Sell
-1,136
Closed -$207K 177
2024
Q1
$207K Buy
+1,136
New +$196K 0.12% 174
2018
Q1
Sell
-19,581
Closed -$1.89M 108
2017
Q4
$1.89M Buy
+19,581
New +$1.85M 1.04% 34

Other funds holding ABBV

Pacific Sun Financial's ABBV Position: Q2 2026 in Review

Pacific Sun Financial held its AbbVie (ABBV) position steady in Q2 2026 at 1,136 shares worth $286K. The position accounts for 0.12% of the portfolio, ranked #175.

Pacific Sun Financial first reported a position in ABBV in Q4 2017 and has held it in 10 quarters since. The position peaked at $1.89M in Q4 2017. 4,216 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pacific Sun Financial held 1,136 shares of AbbVie worth $286K as of Q2 2026.
  • Pacific Sun Financial left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.12% of Pacific Sun Financial's portfolio in Q2 2026, its #175 holding.
  • Pacific Sun Financial first reported a position in AbbVie in Q4 2017 and has held it in 10 quarters since.
  • Pacific Sun Financial's AbbVie position peaked at $1.89M in Q4 2017.
  • 4,216 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pacific Sun Financial's 13F filing for Q2 2026, filed 10 Aug 2026.